LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY

PURPOSE: To evaluate long-term efficacy and safety of ranibizumab for treatment of myopic choroidal neovascularization (mCNV) in clinical practice. METHODS: Noninterventional, retrospective cohort study of East-Asian patients previously treated with ranibizumab during the RADIANCE trial. Forty-one p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Nikolle W., Ohno-Matsui, Kyoko, Koh, Hyoung J., Nagai, Yoshimi, Pedros, Montse, Freitas, Rita L., Macfadden, Wayne, Lai, Timothy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2018
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221407/
https://www.ncbi.nlm.nih.gov/pubmed/28961671
http://dx.doi.org/10.1097/IAE.0000000000001858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221407/
https://www.ncbi.nlm.nih.gov/pubmed/28961671
http://dx.doi.org/10.1097/IAE.0000000000001858

Ejemplares similares